AB001: Phase II data

Top-line data from a double-blind, U.S. Phase II trial in 146 patients with chronic lower back pain showed that AB001 met the primary endpoint

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE